vs

Side-by-side financial comparison of ALLIENT INC (ALNT) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $143.4M, roughly 1.4× ALLIENT INC). REPLIGEN CORP runs the higher net margin — 6.7% vs 4.5%, a 2.3% gap on every dollar of revenue. On growth, ALLIENT INC posted the faster year-over-year revenue change (17.5% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $11.7M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -1.2%).

Allient Inc is a global technology and manufacturing firm that designs, produces, and distributes precision motion, control, and power solutions. It serves core segments including aerospace, defense, medical, industrial automation, and commercial mobility, with operations across North America, Europe, and Asia-Pacific.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

ALNT vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.4× larger
RGEN
$197.9M
$143.4M
ALNT
Growing faster (revenue YoY)
ALNT
ALNT
+3.8% gap
ALNT
17.5%
13.6%
RGEN
Higher net margin
RGEN
RGEN
2.3% more per $
RGEN
6.7%
4.5%
ALNT
More free cash flow
RGEN
RGEN
$5.9M more FCF
RGEN
$17.6M
$11.7M
ALNT
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-1.2%
ALNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALNT
ALNT
RGEN
RGEN
Revenue
$143.4M
$197.9M
Net Profit
$6.4M
$13.3M
Gross Margin
32.4%
52.5%
Operating Margin
7.9%
9.0%
Net Margin
4.5%
6.7%
Revenue YoY
17.5%
13.6%
Net Profit YoY
111.8%
143.9%
EPS (diluted)
$0.38
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALNT
ALNT
RGEN
RGEN
Q4 25
$143.4M
$197.9M
Q3 25
$138.7M
$188.8M
Q2 25
$139.6M
$182.4M
Q1 25
$132.8M
$169.2M
Q4 24
$122.0M
$174.1M
Q3 24
$125.2M
$154.9M
Q2 24
$136.0M
$154.1M
Q1 24
$146.7M
$151.3M
Net Profit
ALNT
ALNT
RGEN
RGEN
Q4 25
$6.4M
$13.3M
Q3 25
$6.5M
$14.9M
Q2 25
$5.6M
$14.9M
Q1 25
$3.6M
$5.8M
Q4 24
$3.0M
$-30.3M
Q3 24
$2.1M
$-654.0K
Q2 24
$1.1M
$3.3M
Q1 24
$6.9M
$2.1M
Gross Margin
ALNT
ALNT
RGEN
RGEN
Q4 25
32.4%
52.5%
Q3 25
33.3%
53.2%
Q2 25
33.2%
50.0%
Q1 25
32.2%
53.6%
Q4 24
31.5%
26.1%
Q3 24
31.4%
50.0%
Q2 24
29.9%
49.8%
Q1 24
32.3%
49.5%
Operating Margin
ALNT
ALNT
RGEN
RGEN
Q4 25
7.9%
9.0%
Q3 25
8.8%
8.9%
Q2 25
8.4%
7.6%
Q1 25
6.6%
3.9%
Q4 24
5.3%
-17.7%
Q3 24
5.3%
-5.1%
Q2 24
3.6%
1.0%
Q1 24
8.2%
1.3%
Net Margin
ALNT
ALNT
RGEN
RGEN
Q4 25
4.5%
6.7%
Q3 25
4.7%
7.9%
Q2 25
4.0%
8.2%
Q1 25
2.7%
3.4%
Q4 24
2.5%
-17.4%
Q3 24
1.7%
-0.4%
Q2 24
0.8%
2.2%
Q1 24
4.7%
1.4%
EPS (diluted)
ALNT
ALNT
RGEN
RGEN
Q4 25
$0.38
$0.24
Q3 25
$0.39
$0.26
Q2 25
$0.34
$0.26
Q1 25
$0.21
$0.10
Q4 24
$0.17
$-0.55
Q3 24
$0.13
$-0.01
Q2 24
$0.07
$0.06
Q1 24
$0.42
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALNT
ALNT
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$40.7M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$301.5M
$2.1B
Total Assets
$577.6M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALNT
ALNT
RGEN
RGEN
Q4 25
$40.7M
$767.6M
Q3 25
$39.5M
$748.7M
Q2 25
$49.9M
$708.9M
Q1 25
$47.8M
$697.2M
Q4 24
$36.1M
$757.4M
Q3 24
$37.1M
$784.0M
Q2 24
$31.3M
$809.1M
Q1 24
$31.5M
$780.6M
Total Debt
ALNT
ALNT
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALNT
ALNT
RGEN
RGEN
Q4 25
$301.5M
$2.1B
Q3 25
$294.2M
$2.1B
Q2 25
$289.1M
$2.1B
Q1 25
$272.8M
$2.0B
Q4 24
$264.9M
$2.0B
Q3 24
$272.9M
$2.0B
Q2 24
$265.7M
$2.0B
Q1 24
$267.1M
$2.0B
Total Assets
ALNT
ALNT
RGEN
RGEN
Q4 25
$577.6M
$2.9B
Q3 25
$585.1M
$2.9B
Q2 25
$588.1M
$2.9B
Q1 25
$586.9M
$2.9B
Q4 24
$575.8M
$2.8B
Q3 24
$596.4M
$2.8B
Q2 24
$595.8M
$2.9B
Q1 24
$611.6M
$2.8B
Debt / Equity
ALNT
ALNT
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALNT
ALNT
RGEN
RGEN
Operating Cash FlowLast quarter
$13.6M
$25.7M
Free Cash FlowOCF − Capex
$11.7M
$17.6M
FCF MarginFCF / Revenue
8.1%
8.9%
Capex IntensityCapex / Revenue
1.3%
4.1%
Cash ConversionOCF / Net Profit
2.12×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$49.7M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALNT
ALNT
RGEN
RGEN
Q4 25
$13.6M
$25.7M
Q3 25
$4.7M
$48.1M
Q2 25
$24.5M
$28.6M
Q1 25
$13.9M
$15.0M
Q4 24
$12.4M
$39.2M
Q3 24
$12.1M
$49.3M
Q2 24
$8.2M
$42.2M
Q1 24
$9.2M
$44.7M
Free Cash Flow
ALNT
ALNT
RGEN
RGEN
Q4 25
$11.7M
$17.6M
Q3 25
$2.8M
$43.4M
Q2 25
$22.4M
$21.5M
Q1 25
$12.9M
$11.4M
Q4 24
$9.6M
$33.6M
Q3 24
$10.5M
$42.3M
Q2 24
$5.8M
$37.4M
Q1 24
$6.2M
$36.4M
FCF Margin
ALNT
ALNT
RGEN
RGEN
Q4 25
8.1%
8.9%
Q3 25
2.0%
23.0%
Q2 25
16.0%
11.8%
Q1 25
9.7%
6.8%
Q4 24
7.9%
19.3%
Q3 24
8.4%
27.3%
Q2 24
4.3%
24.3%
Q1 24
4.2%
24.0%
Capex Intensity
ALNT
ALNT
RGEN
RGEN
Q4 25
1.3%
4.1%
Q3 25
1.4%
2.5%
Q2 25
1.5%
3.9%
Q1 25
0.8%
2.1%
Q4 24
2.3%
3.2%
Q3 24
1.3%
4.5%
Q2 24
1.7%
3.1%
Q1 24
2.0%
5.5%
Cash Conversion
ALNT
ALNT
RGEN
RGEN
Q4 25
2.12×
1.93×
Q3 25
0.72×
3.23×
Q2 25
4.36×
1.92×
Q1 25
3.92×
2.57×
Q4 24
4.11×
Q3 24
5.75×
Q2 24
7.13×
12.70×
Q1 24
1.33×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALNT
ALNT

Industrial And Electronics$69.5M48%
Vehicle$25.7M18%
Other$20.9M15%
Aerospace And Defense$20.6M14%
Distribution And Other Target Market$6.7M5%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons